ÑÝÔ±£¬£¬£¬£¬£¬Ò»¸ö¸ßнÓÖ¸ßΣµÄÖ°Òµ¡£¡£¡£¡£
²»ÉÙ¡°´ò¹¤ÈË¡±ÔÚΪÊÂÇ齹ͷÀöîÖ®¼Ê£¬£¬£¬£¬£¬ÐÄÀï×Ü»áÉú³ö¡°ÈôÊÇÎÒÊÇÑÝÔ±...........¡±µÄÄîÍ·¡£¡£¡£¡£È·Êµ£¬£¬£¬£¬£¬ÑÝÔ±ÐÐÒµ´øÀ´µÄн×ʷdz£¿£¿£¿£¿£¿£¿É¹Û£¬£¬£¬£¬£¬µ«Õâ¸öÖ°ÒµÒ²±£´æ×ÅÒ»¶¨µÄΣº¦¡£¡£¡£¡£
ÓÉÓÚ½ÇÉ«ÐèÒª£¬£¬£¬£¬£¬ÎªÁË»¹Ô¾ç±¾£¬£¬£¬£¬£¬¾´ÒµµÄÑÝÔ±¾³£´¦ÓÚ±°ÁÓµÄÇéÐÎÖ®ÖУ¬£¬£¬£¬£¬ÓÈÆäÊÇÎä´òÑÝÔ±£¬£¬£¬£¬£¬ÆäÖнÏÁ¿µä·¶µÄ¾ÍÊÇÎ⾩¡£¡£¡£¡£
¡¶Õ½ÀÇ¡·ÏµÁС¢¡¶Á÷ÀëµØÇò¡·¡¢¡¶³¤½òºþ¡·µÈ¸ßƱ·¿µÄÓ°Ï·¶¼ÊÇÎ⾩³öȦµÄÕ½¼¨£¬£¬£¬£¬£¬ÔÚ»ñµÃ¹«¹²ÈϿɵÄÈÙÒ«³É¼¨Ê±£¬£¬£¬£¬£¬Î⾩ҲÈÌÊÜ×ÅÒòÅÄÏ·µ¼ÖµÄÉíÌå²»ÊÊ¡£¡£¡£¡£
ÔÚÅÄÉã¡¶Õ½ÀÇ¡·ÏµÁÐʱ´ú£¬£¬£¬£¬£¬Î⾩µÄÏ¥ÊàŦÑ×±¬·¢£¬£¬£¬£¬£¬ÑÏÖØÓ°ÏìËûµÄÉúÑĺÍÊÂÇ飬£¬£¬£¬£¬²»¹ýÔÚ²»¾ÃÖ®ºó£¬£¬£¬£¬£¬¾Í´«À´ÁËÎ⾩ǰÎôÈÕ±¾ÓøÉϸ°ûÖÎÁÆÏ¥ÊàŦÑ×µÄÐÂÎÅ¡£¡£¡£¡£
¸Éϸ°û»¹ÄÜÓÃÀ´ÖÎÁÆÊàŦÑ×£¿£¿£¿£¿£¿£¿ÏàÐÅÕâÊÇÐí¶àÈË¿´µ½ÕâÔòÐÂÎŵĵÚÒ»·´Ó¦¡£¡£¡£¡£
¹ÇÊàŦÑײ¢²»ÓÐÊý£¬£¬£¬£¬£¬ÊÇÍíÄêÈ˵ij£¼û¼²²¡¡£¡£¡£¡£¾Ýͳ¼Æ£¬£¬£¬£¬£¬×èÖ¹2020Ä꣬£¬£¬£¬£¬È«Çò40Ëê¼°ÒÔÉÏÈËȺÖÐÔ¤¼ÆÓÐ6.5ÒÚÈËÊÜÆäÓ°Ï죬£¬£¬£¬£¬ÇÒÅ®ÐÔ»¼²¡ÂʸßÓÚÄÐÐÔ£¬£¬£¬£¬£¬ÆäÖÐÏ¥ÊàŦÑ×ÊǹÇÊàŦÑ××îΪ³£¼ûµÄÊÜÀÛ²¿Î»¡£¡£¡£¡£
´Ó¹ÇÊàŦÑ×µÄÃû³ÆÀ´¿´£¬£¬£¬£¬£¬Ðí¶àÈË»á¼òÆÓµÄÒÔΪÕâÊÇÒ»ÖÖͨË×µÄÑ×Ö¢£¬£¬£¬£¬£¬¿ÉÊÂʵÉÏ£¬£¬£¬£¬£¬¹ÇÊàŦÑ×ÊÇÒ»ÖÖÍËÐÐÐÔ¶àÒòËØ¼²²¡£¬£¬£¬£¬£¬³ýÁËÑ×Ö¢ÐÔת±ä£¬£¬£¬£¬£¬»¹°éÓнṹÐÔ¡¢´úлÐÔת±ä£¬£¬£¬£¬£¬ÊàŦÌÛÍ´¡¢Ö×ÕÍ¡¢½©Ó²¡¢»ûÐÎÊÇÆäÖ÷ÒªÌåÏÖ¡£¡£¡£¡£
ÏÖÔÚ£¬£¬£¬£¬£¬¹ÇÊàŦÑ×µÄÖÎÁƲ½·¥Ö÷Òª°üÀ¨¸Ä±äÉúÑÄ·½·¨£¨Ô˶¯¡¢¼õ·Ê¡¢½äÑÌ£©¡¢ºÍ×¢É䯤ÖÊÀà¹Ì´¼¡¢Í¸Ã÷ÖÊËáµÈÒ©Îï¸ÄÉÆÖ¢×´£¬£¬£¬£¬£¬¼òÆÓÀ´Ëµ£¬£¬£¬£¬£¬¾ÍÊǶÔÖ¢´¦Öóͷ££¬£¬£¬£¬£¬²¢²»¿É×èÖ¹ÊàŦ²¡±äµÄÉú³¤£¬£¬£¬£¬£¬×îÖÕ»¼Õß¿ÉÄÜ·ºÒòÓÉÊàŦ¹¦Ð§Ëðʧ¶ø²Ð¼²µÄÇéÐΡ£¡£¡£¡£
ΪÁËÕü¾ÈÉîÊܹÇÊàŦÑ×ÕÛÄ¥µÄÍíÄêÈË£¬£¬£¬£¬£¬Ò½Ñ§Ñо¿ÕßÏ£ÍûѰÕÒµ½¿ÉÒÔ³¹µ×ÖÎÓú¹ÇÊàŦÑ׵ķ½·¨¡£¡£¡£¡£ÖÕÓÚ£¬£¬£¬£¬£¬»ÊÌì²»¸ºÓÐÐÄÈË£¬£¬£¬£¬£¬ÔÚÒ»Ö±µÄʵÑéºó£¬£¬£¬£¬£¬Ò½Ñ§Ñо¿Õß·¢Ã÷¸Éϸ°û¿ÉÒÔÓÐÓÃÖÎÁÆÊàŦÑס£¡£¡£¡£
ÒÔÊÇ£¬£¬£¬£¬£¬¾Óɶ෬ÑéÖ¤Ö®ºó£¬£¬£¬£¬£¬Î⾩¾öÒéʹÓÃÕâÖÖ·²ÈËδÌý˵¹ýµÄÐÂÐËÁÆ·¨ÖÎÁÆÏ¥ÊàŦÑס£¡£¡£¡£
¸Éϸ°ûÓÐÓÃïÔÌÑ×Ö¢£¬£¬£¬£¬£¬±£»£»¤Èí¹Ç
Óë¹Å°åÖÎÁÆ·½·¨µÄ¶ÔÖ¢´¦Öóͷ£²î±ð£¬£¬£¬£¬£¬¸Éϸ°ûÖÎÁƹÇÊàŦÑ×ÊÇ´Ó»ù´¡ÉÏïÔÌÑ×Ö¢¡¢±£»£»¤Èí¹Ç£¬£¬£¬£¬£¬´Ó¶øÖÎÁƹÇÊàŦÑס£¡£¡£¡£
2019Ä꣬£¬£¬£¬£¬ÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯¡¶Regenerative Medicine¡·ÉϽÒÏþµÄÒ»ÏîÌâΪ¡°Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial¡±µÄÑо¿£¬£¬£¬£¬£¬Ö¤ÊµÁ˸Éϸ°ûÁÆ·¨ÊÇÖÎÁÆÏ¥ÊàŦÑ×µÄÇå¾²ÓÐÓÃÖÎÁÆ·½·¨¡£¡£¡£¡£
¸ÃÏîÑо¿ÊÇΪÁËÆÀ¹À×ÔÌåÖ¬·¾ÈªÔ´µÄ¼ä³äÖʸÉϸ°û£¨ADMSC£©ÖÎÁƶÔÏ¥ÊàŦ¹ÇÊàŦÑ×ÌÛÍ´¡¢¹¦Ð§ºÍ¼²²¡¸Ä±äµÄÁÆÐ§£¬£¬£¬£¬£¬¹²ÄÉÈë30Ãû»¼ÓÐÖ¢×´ÐÔÏ¥ÊàŦ¹ÇÊàŦÑ×»¼Õß×÷ΪÑо¿¹¤¾ß£¬£¬£¬£¬£¬²¢½«ÆäËæ»ú»®·ÖΪÈý×é¡£¡£¡£¡£
ÆäÖУ¬£¬£¬£¬£¬Á½¸öÖÎÁÆ×é½ÓÊÜÊàŦÄÚADMSCÖÎÁÆ£¬£¬£¬£¬£¬·ÖΪµ¥´Î×¢ÉäºÍÁ½´Î×¢Éä¡£¡£¡£¡£µÚÈý×é×÷Ϊ±ÈÕÕ×飬£¬£¬£¬£¬½ÓÄɹŰåÊØ¾ÉÖÎÁÆ£¬£¬£¬£¬£¬ÖÎÁÆËæ·Ãʱ¼äΪ12¸öÔ¡£¡£¡£¡£
±ÈÕÕ×éºÍADMSCÖÎÁÆ×éµÄÉú³Ýͳ¼ÆÑ§ÌØÕ÷
Ñо¿Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬ÔÚËæ·Ã¿¢ÊÂʱ£¬£¬£¬£¬£¬µ¥´Î×¢Éä×éºÍÁ½´Î×¢Éä×éµÄÌÛʹƽ¾ùÖµ»®·Ö´Ó6.7(1.7)ºÍ6.5(1.4)¸ÄÉÆµ½2.6(1.8)ºÍ2.3(2)¡£¡£¡£¡£
²¢ÇÒÓë±ÈÕÕ×éÏà±È£¬£¬£¬£¬£¬µ¥´Î×¢Éä×éºÍÁ½´Î×¢Éä×éÔÚ12¸öÔÂʱÌÛÍ´ÏÔ׿õÇá¡£¡£¡£¡£
Èý×éµÄÊý×ÖÌÛÍ´ÆÀ¶¨Á¿±í
³ýÁËÌÛÍ´ÏÔ׿õÇáÒÔÍ⣬£¬£¬£¬£¬ÔÚÕû¸öËæ·ÃÀú³ÌÖУ¬£¬£¬£¬£¬µ¥´Î×¢Éä×éºÍÁ½´Î×¢Éä×éµÄÊàŦÑ×Ñ×Ö¢Ö¸ÊýÆÀ·Ö¶¼ÓÐËù¸ÄÉÆ£¬£¬£¬£¬£¬ÔÚ×îÏÈÖÎÁÆÇ°£¬£¬£¬£¬£¬Á½×éµÄÊàŦÑ×Ñ×Ö¢Ö¸Êýƽ¾ùÖµ»®·ÖΪ59.6(17.9)ºÍ54.4(18.2)£¬£¬£¬£¬£¬ÔÚ12¸öÔÂʱ»®·Ö¸ÄÉÆÖÁ84(9.4)ºÍ87.3(8)¡£¡£¡£¡£
Óë±ÈÕÕ×éÏà±È£¬£¬£¬£¬£¬Á½¸öÖÎÁÆ×éµÄÊàŦÑ×Ñ×Ö¢Ö¸Êý¶¼ÓÐÏÔÖø¸ÄÉÆ¡£¡£¡£¡£
Èý×éµÄÊàŦÑ×Ñ×Ö¢Ö¸ÊýÆÀ·Ö
×îΪÖ÷ÒªµÄÊÇ£¬£¬£¬£¬£¬ÔÚÍê³É12¸öÔµÄËæ·Ãºó·¢Ã÷£¬£¬£¬£¬£¬ÔÚ±ÈÕÕ×éÖУ¬£¬£¬£¬£¬ÓÐ67%µÄ»¼ÕßÓÐÈí¹ÇɥʧµÄÏ£Íû£¬£¬£¬£¬£¬ÓÐ56%µÄ»¼ÕßÓйÇ׸ÐγɵÄÏ£Íû¡£¡£¡£¡£
¶øÔÚµ¥´Î×¢Éä×éÖУ¬£¬£¬£¬£¬Ö»¹ÜÓÐ50%µÄ»¼ÕßÔÚ12¸öÔÂʱ¹Ç׸ÐγÉÏ£Íû£¬£¬£¬£¬£¬µ«Ö»ÓÐ30%µÄ»¼ÕßÓнøÒ»²½µÄÈí¹Çɥʧ¡£¡£¡£¡£ÔÚÁ½´Î×¢Éä×éÖУ¬£¬£¬£¬£¬²»µ«ÓÐ89%µÄ»¼ÕßÈí¹Ç¸ÄÉÆ»òÈí¹ÇɥʧÎÞÏ£Íû£¬£¬£¬£¬£¬²¢ÇÒÓÐ89%µÄ¼ÓÈëÕß¹Ç׸ÐγÉÎÞÏ£Íû¡£¡£¡£¡£
½øÒ»²½ÆÊÎöЧ¹ûÏÔʾ£¬£¬£¬£¬£¬ÔÚÈý¸ö×éÖУ¬£¬£¬£¬£¬Ö»ÓÐÁ½´Î×¢Éä×éÏÔʾ±£´æÈí¹ÇËðʧ¸ÄÉÆÇéÐΡ£¡£¡£¡£
ÖµµÃÒ»ÌáµÄÊÇ£¬£¬£¬£¬£¬ÔÚÕû¸öÑо¿Àú³ÌÖУ¬£¬£¬£¬£¬Á½´Î×¢Éä×éûÓÐÊӲ쵽Ïà¹ØµÄÑÏÖØ²»Á¼ÊÂÎñ¡£¡£¡£¡£
Ò»´Î×¢ÉäºÍÁ½´Î×¢ÉäÖÎÁÆ×éµÄ²»Á¼·´Ó¦
Á¬ÏµÒÔÉÏÊý¾Ý£¬£¬£¬£¬£¬¿ÉÒÔ¿´³ö£¬£¬£¬£¬£¬ÔÚÍê³É12¸öÔµÄËæ·Ãʱ£¬£¬£¬£¬£¬½ÓÊÜADMSCsµÄÁ½¸öÖÎÁÆ×é¶¼ÌåÏÖ³öÁÙ´²ÏÔÖøµÄÌÛÍ´ºÍ¹¦Ð§¸ÄÉÆ¡£¡£¡£¡£
Òò´Ë£¬£¬£¬£¬£¬Ñо¿Õߵóö½áÂÛ£º×ÔÌåADMSCÖÎÁÆÊÇÏ¥ÊàŦ¹ÇÊàŦÑ×Çå¾²ÓÐÓõÄÖÎÁÆÒªÁ죬£¬£¬£¬£¬²¢¿ÉÄܾßÓÐÔ¤·À¼²²¡Ï£ÍûµÄDZÁ¦¡£¡£¡£¡£
×ܽá
Î⾩ÔÚ¾ÓɸÉϸ°ûÖÎÁƺ󣬣¬£¬£¬£¬Ï¥ÊàŦÑ×»ñµÃºÜºÃµÄ¸ÄÉÆ£¬£¬£¬£¬£¬´Ó½ü¼¸ÄêµÄÅÄÉã³ÉƬÇéÐÎÀ´¿´£¬£¬£¬£¬£¬Ëû»Ö¸´µÄÇéÐνϺ㬣¬£¬£¬£¬²¢²»Ó°ÏìËû¾ÙÐнϸßÄѶȵÄÐж¯ÅÄÉã¡£¡£¡£¡£
¸Éϸ°ûÖÎÁƵķºÆð£¬£¬£¬£¬£¬¸üÐÂÁ˹ÇÊàŦÑ×µÄÖÎÁÆÑ¡ÏîÁÐ±í£¬£¬£¬£¬£¬Î⾩µÄÀÖ³ÉʵÑ鏸Ðí¶àÔ±¾Ö»ÄܶÔÖ¢ÖÎÁƵĹÇÊàŦÑ×»¼Õß´øÀ´ÁËÃãÀøºÍÏ£Íû£¬£¬£¬£¬£¬Ï£ÍûÕâЩÉîÊܹÇÊàŦÑ×ÕÛÄ¥µÄ¡°²»ÐÒÕß¡±¿ÉÒÔÔçÈÕ±»¸Éϸ°ûÕü¾È¡£¡£¡£¡£
²Î¿¼ÎÄÏ×£º
1¡¢Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A, Paterson K, Boyd R. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019 Mar;14(3):213-230. doi: 10.2217/rme-2018-0161. Epub 2019 Feb 14. PMID: 30762487.